Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer
- 20 December 2017
- journal article
- clinical trial
- Published by Walter de Gruyter GmbH in Drug Metabolism and Personalized Therapy
- Vol. 32 (4) , 209-218
Abstract
Background: Fluoropyrimidines form the chemotherapy backbone of advanced and metastatic colorectal cancer (CRC). These drugs are frequently associated with toxicity events that result in dose adjustments and even suspension of the treatment. The thymidylate synthase (Methods: Variants namely rs45445694, rs183205964, rs2853542 and rs151264360 ofResults: The 2R/2R (rs45445694) was associated with clinical response (p=0.05, odds ratio (OR)=3.45) and severe toxicity (p=0.0014, OR=5.21, from pooled data). Expression analysis in tumor tissues suggested a correlation between the 2R/2R genotype and lowConclusions: The allele 2R (rs45445694) predicts severe toxicity and objective response in advanced CRC patients. In addition, the alleles G(rs2853542) and 6bp-(rs151264360) are independent predictors of response failure to chemotherapy. This is the first study made on a Latin American population that points outKeywords
This publication has 48 references indexed in Scilit:
- Optimizing Adjuvant Therapy and Survivorship Care of Stage III Colon CancerFuture Oncology, 2016
- Current Approaches for TYMS Polymorphisms and their Importance in Molecular Epidemiology and PharmacogeneticsPharmacogenomics, 2013
- Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapyColorectal Disease, 2013
- The Association of Polymorphisms in 5-Fluorouracil Metabolism Genes with Outcome in Adjuvant Treatment of Colorectal CancerPharmacogenomics, 2011
- Ancestry informative markers and admixture proportions in northeastern MexicoJournal of Human Genetics, 2009
- Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracilPharmacogenetics and Genomics, 2005
- Relationship Between Thymidylate Synthase (TS) Genotype and TS Expression: A Tissue Microarray Analysis of Colorectal CancersInternational Journal of Surgical Pathology, 2005
- 5-Fluorouracil: mechanisms of action and clinical strategiesNature Reviews Cancer, 2003
- Universal and rapid salt-extraction of high quality genomic DNA for PCR- based techniquesNucleic Acids Research, 1997
- Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase.Cell Structure and Function, 1995